Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor

Ahmed, 2016, An osteopontin/CD44 axis in RhoGDI2-mediated metastasis suppression, Cancer Cell, 30, 432, 10.1016/j.ccell.2016.08.002 Beltran, 2016, Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer, Nat. Med., 22, 298, 10.1038/nm.4045 Beltran, 2011, Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets, Cancer Discov., 1, 487, 10.1158/2159-8290.CD-11-0130 Brawley, 2012, Trends in prostate cancer in the United States, J. Natl. Cancer Inst. Monogr., 2012, 152, 10.1093/jncimonographs/lgs035 Cai, 2016, Recent advances in adipose mtor signaling and function: therapeutic prospects, Trends Pharmacol. Sci., 37, 303, 10.1016/j.tips.2015.11.011 Calle, 2004, Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms, Nat. Rev. Cancer, 4, 579, 10.1038/nrc1408 Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N. Engl. J. Med., 348, 1625, 10.1056/NEJMoa021423 Cao, 2011, Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis, Cancer Prev. Res. (Phila.), 4, 486, 10.1158/1940-6207.CAPR-10-0229 De Marzo, 2007, Inflammation, atrophy, and prostate carcinogenesis, Urol. Oncol., 25, 398, 10.1016/j.urolonc.2007.05.007 Duran, 2011, p62 is a key regulator of nutrient sensing in the mTORC1 pathway, Mol. Cell, 44, 134, 10.1016/j.molcel.2011.06.038 Duran, 2004, The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis, Dev. Cell, 6, 303, 10.1016/S1534-5807(03)00403-9 Finkelstein, 2005, Economic causes and consequences of obesity, Annu. Rev. Public Health, 26, 239, 10.1146/annurev.publhealth.26.021304.144628 Finley, 2009, Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness, J. Urol., 182, 1621 Freedland, 2007, Obesity and prostate cancer: making sense out of apparently conflicting data, Epidemiol. Rev., 29, 88, 10.1093/epirev/mxm006 Greenberg, 1995, Prostate cancer in a transgenic mouse, Proc. Natl. Acad. Sci. USA, 92, 3439, 10.1073/pnas.92.8.3439 Ittmann, 2013, Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee, Cancer Res., 73, 2718, 10.1158/0008-5472.CAN-12-4213 Keto, 2012, Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database, BJU Int., 110, 492, 10.1111/j.1464-410X.2011.10754.x Kir, 2016, Cachexia & brown fat: a burning issue in cancer, Trends Cancer, 2, 461, 10.1016/j.trecan.2016.07.005 Lee, 2013, Identification of an adipogenic niche for adipose tissue remodeling and restoration, Cell Metab., 18, 355, 10.1016/j.cmet.2013.08.003 Li, 2010, Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis, Proc. Natl. Acad. Sci. USA, 107, 3441, 10.1073/pnas.0914798107 Linares, 2015, Amino acid activation of mTORC1 by a PB1-domain-driven kinase complex cascade, Cell Rep., 12, 1339, 10.1016/j.celrep.2015.07.045 Liu, 2006, Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer, Prostate Cancer Prostatic Dis., 9, 230, 10.1038/sj.pcan.4500879 MacInnis, 2006, Body size and composition and prostate cancer risk: systematic review and meta-regression analysis, Cancer Causes Control, 17, 989, 10.1007/s10552-006-0049-z Moscat, 2016, p62 in cancer: signaling adaptor beyond autophagy, Cell, 167, 606, 10.1016/j.cell.2016.09.030 Muller, 2013, p62 links beta-adrenergic input to mitochondrial function and thermogenesis, J. Clin. Invest., 123, 469, 10.1172/JCI64209 Nieman, 2011, Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth, Nat. Med., 17, 1498, 10.1038/nm.2492 Olson, 2006, Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy, Cancer Gene Ther., 13, 676, 10.1038/sj.cgt.7700941 Ouchi, 2011, Adipokines in inflammation and metabolic disease, Nat. Rev. Immunol., 11, 85, 10.1038/nri2921 Park, 2010, Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression, Cell, 140, 197, 10.1016/j.cell.2009.12.052 Petruzzelli, 2014, A switch from white to brown fat increases energy expenditure in cancer-associated cachexia, Cell Metab., 20, 433, 10.1016/j.cmet.2014.06.011 Rakhshandehroo, 2010, Peroxisome proliferator-activated receptor alpha target genes, PPAR Res., 2010, 10.1155/2010/612089 Rangaswami, 2006, Osteopontin: role in cell signaling and cancer progression, Trends Cell Biol., 16, 79, 10.1016/j.tcb.2005.12.005 Reina-Campos, 2017, Metabolism shapes the tumor microenvironment, Curr. Opin. Cell Biol., 48, 47, 10.1016/j.ceb.2017.05.006 Rodriguez, 2006, Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62, Cell Metab., 3, 211, 10.1016/j.cmet.2006.01.011 Rodriguez, 2001, Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States, Cancer Epidemiol. Biomarkers Prev., 10, 345 Schlaepfer, 2014, Lipid catabolism via CPT1 as a therapeutic target for prostate cancer, Mol. Cancer Ther., 13, 2361, 10.1158/1535-7163.MCT-14-0183 Shevde, 2010, Osteopontin: an effector and an effect of tumor metastasis, Curr. Mol. Med., 10, 71, 10.2174/156652410791065381 Sutcliffe, 2007, Inflammation in the etiology of prostate cancer: an epidemiologic perspective, Urol. Oncol., 25, 242, 10.1016/j.urolonc.2006.09.014 Valencia, 2014, Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis, Cancer Cell, 26, 121, 10.1016/j.ccr.2014.05.004 Venkateswaran, 2007, Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts, J. Natl. Cancer Inst., 99, 1793, 10.1093/jnci/djm231 von Hafe, 2004, Visceral fat accumulation as a risk factor for prostate cancer, Obes. Res., 12, 1930, 10.1038/oby.2004.242 Wolin, 2010, Obesity and cancer, Oncologist, 15, 556, 10.1634/theoncologist.2009-0285 Wright, 2007, Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality, Cancer, 109, 675, 10.1002/cncr.22443